Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020:25:102062.
doi: 10.1016/j.nicl.2019.102062. Epub 2019 Nov 1.

Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An 123I-FP-CIT SPECT study

J J van der Zande  1 , M Joling  2 , I G Happach  3 , C Vriend  4 , Ph Scheltens  3 , J Booij  5 , A W Lemstra  3
Affiliations

Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An 123I-FP-CIT SPECT study

J J van der Zande et al. Neuroimage Clin. 2020.

Abstract

Purpose: To study the influence of concomitant Alzheimer's disease (AD) pathology in dementia with Lewy bodies (DLB) on dopamine transporter (DAT) and serotonin transporter (SERT) availability, using 123I-N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) nortropane (123I-FP-CIT) single photon emission computed tomography (SPECT).

Methods: Based on their cerebrospinal fluid biomarker profile, fifty-two patients with probable DLB were divided in a group with (DLB/AD+, N = 15) and without concomitant AD-pathology (DLB/AD-, N = 37). We conducted atrophy-corrected region of interest (ROI) analyses comparing binding ratios (BRs) in the DAT-rich striatal and SERT-rich extrastriatal brain areas (amygdala, hippocampus, thalamus, midbrain and pons).

Results: DLB/AD+ patients had significantly lower 123I-FP-CIT BRs in the left amygdala, and a trend was seen in the right hippocampus. Groups did not differ significantly in striatal 123I-FP-CIT BRs, neuropsychiatric or motor symptoms. Motor symptoms correlated negatively with striatal DAT BRs.

Conclusions: DLB/AD+ patients may have lower SERT binding in limbic brain regions than DLB/AD- patients, possibly indicating faster neurodegeneration in mixed pathology.

Keywords: (123)I-FP-CIT SPECT; Alzheime’s disease; Dementia with Lewy bodies; Dopamine transporter; Serotonin transporter.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no conflicts of interest.

Figures

Fig1
Fig.1
Distribution of 123I-FP-CIT binding ratios (BRs) in the amygdala and hippocampus of DLB-patients with (DLB/AD+) and without (DLB/AD-) concomitant Alzheimer-pathology.
See this image and copyright information in PMC

References

    1. Chang L.T. Method for attenuation correction in radionuclide computed tomography. IEEE Trans. Nucl. Sci. 1978;25:638–643.
    1. Del Sole A. Correlation between 123I-FP-CIT brain SPECT and parkinsonism in dementia with Lewy bodies: caveat for clinical use. Clin. Nucl. Med. 2015;40(1):32–35. - PubMed
    1. Duits F.H. The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean? Alzheimers Dement. 2014;10(6) 713–723 e2. - PubMed
    1. Howlett D.R. Regional multiple pathology scores are associated with cognitive decline in Lewy body dementias. Brain Pathol. 2015;25(4):401–408. - PMC - PubMed
    1. Joling M. Lower (123)I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies. Neuroimage Clin. 2018;19:130–136. - PMC - PubMed

Publication types

MeSH terms

Substances